Transport of thiophenorphine across Caco-2 monolayer model

Chinese Journal of Pharmacology and Toxicology

Volumn 24, Issue 1, 2010, Pages 64-68

  Li, Zheng ^a   Zhuang, Xiao Mei ^a   Li, Su Yun ^b   Zhang, Zhen Qing ^a   Ruan, Jin Xiu ^a  

^a BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cells, cultured; Chromatography, high pressure liquid; Glycoproteins; Multidrug resistance associated proteins; Thiophenorphine

Indexed keywords

CALCEIN; CYCLOSPORIN A; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 2; THIOPHENE DERIVATIVE; THIOPHENORPHINE; UNCLASSIFIED DRUG; VERLUKAST;

ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 77749337578     PISSN: 10003002     EISSN: None     Source Type: Journal    
DOI: 10.3867/j.issn.1000-3002.2010.01.011     Document Type: Article

References (13)

1. Chinese source
2. Chinese source
3. Djuv A, Nilsen OG. Caco-2 cell methodology and inhibition of the P-glycoprotein transport of digoxin by Aloe vera juice [J]. Phytother Res, 2008, 22(12): 1623-1628.
4. Inokuchi H, Takei T, Aikawa K, Shimizu M. The effect of hyperosmosis on paracellular permeability in Caco-2 cell monolayers [J]. Biosci Biotechnol Biochem, 2009, 73(2): 328-334.
5. Lalloo AK, Luo FR, Guo A, Paranjpe PV, Lee SH, Vyas V, et al. Membrane transport of camptothecin : facilitation by human P-glycoprotein (ABCB1) and multidrug resistance protein 2 (ABCC2) [J]. BMC Med, 2004, 2: 16.
6. von Richter O, Glavinas H, Krajcsi P, Liehner S, Siewert B, Zech K. A novel screening strategy to identify ABCB1 substrates and inhibitors [ J ]. Naunyn Schmiedebergs Arch Pharmacol, 2009, 379(1): 11-26.
7. Tan W, Chen H, Zhao J, Hu J, Li Y. A study of intestinal absorption of bicyclol in rats : active efflux transport and metabolism as causes of its poor bioavailability [J]. J Pharm Pharm Sci, 2008, 11(3): 97-105.
8. Roy JN, Barama A, Poirier C, Vinet B, Roger M. Cyp3A4, Cyp3A5, and MDR-1 genetic influences on tacrolimus pharmacokinetics in renal transplant recipients [J]. Pharmacogenet Genomics, 2006, 16(9): 659-665.
9. Chen J, Raymond K. Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor [J]. Ann Clin Microbiol Antimicrob, 2006, 5: 3.
10. Föger F, Kopf A, Loretz B, Albrecht K, BernkopSchnürch A. Correlation of in vitro and in vivo models for the oral absorption of peptide drugs [J]. Amino Acids, 2008, 35(1): 233-241.
11. Artursson P, Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability co-efficients in human intestinal epithelial (Caco-2) cells [J]. Biochem Biophys Res Commun, 1991, 175(3): 880-885.
12. Hu M, Chen J, Zhu Y, Dantzig AH, Stratford RE Jr, Kuhfeld MT. Mechanism and kinetics of transcellular transport of a new beta-lactam antibiotic loracarbef across an intestinal epithelial membrane model system (Caco-2) [J]. Pharm Res, 1994, 11(10): 1405-1413.
13. Sun H, Pang KS. Permeability, transport, and metabolism of solutes in Caco-2 cell monolayers: a theoretical study [J]. Drug Metab Dispos, 2008, 36(1): 102-123.